期刊文献+

SUMO融合系统高效表达可溶性鼠源FGF-21及其活性的研究 被引量:7

Utilization of SUMO expression vector to efficiently express mouse FGF-21 and studying of its bioactivity
在线阅读 下载PDF
导出
摘要 利用SUMO表达载体在大肠杆菌中高效可溶性表达鼠源成纤维细胞生长因子(FGF-21)成熟蛋白,并研究其调节血糖的功能。将鼠源FGF-21成熟蛋白基因亚克隆至SUMO表达载体上,在大肠杆菌Rosetta(DE3)中诱导表达,并用镍离子螯合柱(Ni-NTA)纯化重组蛋白,透析后利用SUMO蛋白酶I切割融合蛋白,获得纯度较高的成熟蛋白。将3T3-L1成纤维细胞分化成脂肪细胞,经微量化的GOD-POD法检测培养基中葡萄糖含量,统计学分析葡萄糖消耗率。结果表明,在SUMO表达体系中鼠源FGF-21成熟蛋白基因以可溶形式表达,且可被SUMO蛋白酶I有效地切割,获得纯度较高的成熟蛋白。与未经处理的脂肪细胞对照组相比,经鼠源FGF-21成熟蛋白处理后脂肪细胞对葡萄糖的摄取利用显著增加,残存在培养基中的葡萄糖含量明显减少;两样本比较的t检验,P<0.001,差异极显著。 The objective of the paper is to utilize SUMO expression vector to efficiently express mouse fibroblast growth factor (FGF)-21. Glucose regulation activity was studied for mouse mature FGF-21 protein. The cDNA of mouse mature FGF-21 protein was subcloned into the SUMO expression vector. The recombinant plasmids were transformed into Escherichia coli Rosetta (DE3) and the expressed recombinant protein was purified by its binding column. The purified recombinant protein was dialyzed against PBS. The fusion protein could be efficiently cleaved by SUMO protease I to obtain pure and active recombinant protein. To examine the glucose regulation activity of mFGF-21, 3T3-L1 pre-adipocytes were differentiated into adipocytes, glucose uptake activity of mFGF-21 was examined by Glucose Oxidase and Peroxidase (GOD-POD) assay. The cDNA of mouse mature FGF-21 protein was expressed in soluble form and the recombinant protein accounted for 50% of total bacterial protein in the SUMO expression system. Mouse FGF-21 possessed strong bioactivity for glucose homeostasis in 3T3-L1 adipocytes. And mouse FGF-21 could stimulate glucose uptake of 3T3-L1 adipocytes in dose-dependent manner.
出处 《东北农业大学学报》 CAS CSCD 北大核心 2009年第5期62-67,共6页 Journal of Northeast Agricultural University
基金 黑龙江省科技厅重点攻关项目(2006G0461-00)
关键词 SUMO SUMO蛋白酶I 分子伴侣 鼠源FGF-21 葡萄糖吸收 SUMO SUMO protease I molecular chaperones mouse FGF-21 glucose up-take
  • 相关文献

参考文献17

  • 1Wente W,Efanov A M,Brenner M,et al.Fibroblast growth factor-21 improves pancreatic-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and akt signaling pathways[J].Diabetes,2006,55:2470-2478.
  • 2Kharitonenkov A,Wroblewski V J,Koester A,et al.The metabolic state of diabetic monkeys is regulated by fibroblast growth factor21[J].Endocrinology,2007,148:774-781.
  • 3Kharitonenkov A,Shiyanova TL,Koester A,et al.FGF-21 as anovel metabolic regulator[J].J Clin Invest,2005,115:1627-1635.
  • 4任桂萍,李璐,孙国鹏,侯玉婷,王文飞,李德山.成纤维细胞生长因子(FGF)受体-2参与FGF-21介导的糖代谢活性[J].生物化学与生物物理进展,2009,36(2):165-174. 被引量:11
  • 5姜媛媛,刘铭瑶,任桂萍,王文飞,刘晓民,李德山.鼠源成纤维细胞生长因子-21对脂肪细胞糖代谢的作用[J].生物化学与生物物理进展,2009,36(2):157-164. 被引量:18
  • 6Marblestone J G,Edavettal S C,Lim Y,et al.Comparison of SUMO fusion technology with traditional gene fusion systems:Enhanced expression and solubility with SUMO[J].Protein Science,2006,15:182-189.
  • 7Malakhov M P,Mattern M R,Malakhov O A,et al.SUMO fusions and SUMO-specific protease for efficient expression and purification of proteins[J].Struct Funct Gen,2004(5):75-86.
  • 8Butt T R,Edavettal S C,Hall J P,et al.SUMO fusion technology for difficult-to-express proteins[J].Protein Expr Purif,2005,43(1):1-9.
  • 9Sambrook J,Fritsch E F,Manutus T.Molecular cloning,a laboratory manual[M].2nd ed.New York:Cold Spring Harbor Laboratary Press,1989:880-898.
  • 10Ansubel F M,Brent R,Kingston R E,et al.Short protocols in molecular biology[M].3rd ed.Boston:John Wiley & Sons Inc,1992:652-658.

二级参考文献65

  • 1Uusitupa M I, Niskanen L K, Siitonen O, et al. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipo-protein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia, 1993, 36 (11): 1175-1184
  • 2Clark C M Jr. How should we respond to the worldwide diabetes epidemic. Diabetes Care, 1998, 21(4): 475-476
  • 3Aiello L P, Gardner T W, King G L, et al. Diabetic retinopathy. Diabetes Care, 1998, 21(1): 143-156
  • 4Mooradian A D. Drug therapy of non-insulin-dependent diabetes mellitus in the elderly. Drugs, 1996, 51(6): 931 -941
  • 5Scheen A J. Drug treatment of non-insulin-dependent diabetes mellitus in the 1990s. Achievements and future developments. Drugs, 1997, 54(3): 355-368
  • 6Wente W, Efanov A M, Brenner M, et al. Fibroblast growth factor-21 improves pancreatic-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and akt signaling pathways. Diabetes, 2006, 55(9): 2470-2478
  • 7Kharitonenkov A, Wroblewski V J, Koester A, et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21. Endocrinology, 2007, 148(2): 774-781
  • 8Kharitonenkov A, Shiyanova T L, Koester A, et al. FGF-21 as a novel metabolic regulator. J Clin Invest, 2005, 115(6): 1627-1635
  • 9Marblestone J G, Edavettal S C, Lim Y, et al. Comparison of SUMO fusion technology with traditional gene fusion systems: Enhanced expression and solubility with SUMO. Protein Science,15(1): 182- 189
  • 10Bornstein P, Balian G. Cleavage at Asn-Gly bonds with hydroxylamine. Meth Enzy-Mol, 1997, 47(Part E): 132- 145

共引文献65

同被引文献47

  • 1井明艳,孙建义.蛋白质的折叠调控与包涵体的形成[J].浙江大学学报(农业与生命科学版),2004,30(6):690-696. 被引量:27
  • 2高飞,范清林,邹文艺,宋礼华.包涵体蛋白的层析复性技术研究进展[J].生物技术通报,2006,22(2):56-59. 被引量:2
  • 3Itoh N, Ornitz D M. Evolution of the FGF and FGFR gene families [J]. TRENDS in Genetics, 2004, 20(11): 563-569.
  • 4Nishimura T, Nakatake Y, Konishi M, et al. Identification of a novel FGF, FGF-21, preferentially expressed in the liver [J]. Biochim Biophys Acta, 2000, 1492: 203-206.
  • 5Wang H, Qiang L, Farmer S R. Identification of a domain within peroxisome proliferator-aetivated receptor gamma regulating ex- pression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes[J]. Mol Cell Biol, 2008, 28, 188-200.
  • 6Izumiya Y, Bina H A, Ouchi N, et al. FGF21 is an Akt-regulated myokine [J]. FEBS Lett, 2008, 582, 3805-3810.
  • 7Kharitonenkov A, Shiyanova T L, Koester A et al. FGF-21 as a novel metabolic regulator[J]. Journal of Clinical Investigation, 2005, 115(6): 1627-1635.
  • 8Xu J, Lloyd D J, Hale C, et al. Fibroblast growth factor 21 revers- es hepatic steatosis, Increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice[J]. Diabetes, 2009, 58(1): 250-259.
  • 9Kharitonenkov A, Wroblewski V. J., Koester, A. et al. The metabolic state of diabetic monkeys is regulated by fibroblast growth factor-21[J]. Endocrinology, 2007, 148(2): 774-781.
  • 10Stauber D J, Digabriele A D, Hendrickson W A. Structural interactions of fibroblast growth factor receptor with its ligands[J].PNAS, 2000, 97: 49-54.

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部